Chengdu Easton Biopharmaceuticals (688513.SHG) Q4 2024 Earnings

Oct 25Confirmed
Q2 2023
Q2 2024
Q3 2024
Q4 2024
0.59
0.92
1.25
1.59

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Chengdu Easton Biopharmaceuticals⁩ (⁦688513.SHG⁩) will report earnings of for ⁦Q4 2024⁩ on October 25, 2024.

0 Comments

Share your thoughts